Eu Chang Hwang

4.2k citations
229 papers · 2.8k indexed · 1 hit paper · h-index 26

Eu Chang Hwang

204 papers receiving 2.8k citations

Hit Papers

Prostate cancer screening with prostate-specific antigen ...3912018202620202023100200300

Peers

Eu Chang Hwang
Comparison fields: 5 of 127
  • Urology 475
  • Pulmonary and Respiratory Medicine 1.3k
  • Oncology 648
  • Cancer Research 317
  • Surgery 901
Replace Giuseppe Carrieri with:
Giuseppe Carrieri Italy
Felice Crocetto Italy
Mark A. Preston United States
Takuya Koie Japan
Muta M. Issa United States
Luigi Cormio Italy
Kyo Chul Koo South Korea
Pierfrancesco Bassi Italy
Gopal N. Gupta United States
Nicolò Maria Buffi Italy
Eu Chang Hwang relative to Giuseppe Carrieri Italy Giuseppe Carrieri's profile →
Citations per field
00.5×1.6×
Giuseppe Carrieri · 1×
Citations per year

Countries citing papers authored by Eu Chang Hwang

Since Specialization
Citations

This map shows the geographic impact of Eu Chang Hwang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eu Chang Hwang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eu Chang Hwang more than expected).

Fields of papers citing papers by Eu Chang Hwang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eu Chang Hwang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eu Chang Hwang. The network helps show where Eu Chang Hwang may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Eu Chang Hwang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eu Chang Hwang Line = papers co-authored together Eu Chang Hwang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20240
3 20242
4 20241
5 20236
6 20228
7 20224
8 20220
9 20221
10 20206
11 202019
12 20203
13 202011
14 201912
15 20187
16 201624
17 201620
18 20146
19 201121
20 20115

About Eu Chang Hwang

Eu Chang Hwang is a scholar working on Urology, Pulmonary and Respiratory Medicine and Surgery, having authored 229 papers that have together received 2.8k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (58 papers), Bladder and Urothelial Cancer Treatments (44 papers), Prostate Cancer Diagnosis and Treatment (38 papers), Urinary Bladder and Prostate Research (37 papers), Renal and related cancers (31 papers), Urinary and Genital Oncology Studies (28 papers), Urinary Tract Infections Management (24 papers) and Urological Disorders and Treatments (24 papers). The work is most often cited by research in Urology (475 citations), Pulmonary and Respiratory Medicine (1.3k citations) and Oncology (648 citations). Eu Chang Hwang has collaborated with scholars based in South Korea, United States and Canada. Frequent co-authors include Kwangsung Park, Philipp Dahm, Seung Il Jung, Jae Hung Jung, Taek Won Kang, Sun‐Ouck Kim, Anne Cleves, Dong Deuk Kwon, Mia Djulbegovic and Thomas Agoritsas. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026